2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Skeletal muscle metastasis with bone metaplasia from colon cancer: A case report and review of the literature

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          Colon cancer is a common malignant disease of the gastrointestinal tract and usually occurs at the junction of the rectum and sigmoid colon. Lymphatic and hematogenous metastases occur frequently in colon cancer and the most common metastatic sites include the liver, lung, peritoneum, bone, and lymph nodes. As a manifestation of advanced tumor spread and metastasis, soft tissue metastasis, especially skeletal muscle metastasis with bone metaplasia caused by colon cancer, is rare, accounting for less than 1% of metastases.

          CASE SUMMARY

          A 43-year-old male patient developed skeletal muscle metastasis with bone metaplasia of the right proximal thigh 5 mo after colon cancer was diagnosed. The patient was admitted to the hospital because of pain caused by a local mass on his right thigh. Positron emission tomography-computed tomography showed many enlarged lymph nodes around the abdominal aorta but no signs of lung or liver metastases. Color ultrasound revealed a mass located in the skeletal muscle and the results of histological biopsy revealed a poorly differentiated adenocarcinoma suspected to be distant metastases from colon cancer. Immunohistochemistry showed small woven bone components that were considered to be ossified.

          CONCLUSION

          This case reminds us that for patients with advanced colorectal tumors, we should be alert to the possibility of unconventional metastasis.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: found

          Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

          Patients with metastatic colorectal cancer with the BRAF V600E mutation have a poor prognosis, with a median overall survival of 4 to 6 months after failure of initial therapy. Inhibition of BRAF alone has limited activity because of pathway reactivation through epidermal growth factor receptor signaling.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            NCCN Guidelines Insights: Colon Cancer, Version 2.2018

            The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rho GTPases in cell biology.

              Rho GTPases are molecular switches that control a wide variety of signal transduction pathways in all eukaryotic cells. They are known principally for their pivotal role in regulating the actin cytoskeleton, but their ability to influence cell polarity, microtubule dynamics, membrane transport pathways and transcription factor activity is probably just as significant. Underlying this biological complexity is a simple biochemical idea, namely that by switching on a single GTPase, several distinct signalling pathways can be coordinately activated. With spatial and temporal activation of multiple switches factored in, it is not surprising to find Rho GTPases having such a prominent role in eukaryotic cell biology.
                Bookmark

                Author and article information

                Contributors
                Journal
                World J Clin Cases
                WJCC
                World Journal of Clinical Cases
                Baishideng Publishing Group Inc
                2307-8960
                26 October 2021
                26 October 2021
                : 9
                : 30
                : 9285-9294
                Affiliations
                Department of General Surgery, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China
                Department of Dermatology, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China
                Department of General Surgery, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China
                Department of General Surgery, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China
                Department of General Surgery, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China
                Department of General Surgery, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China
                Department of General Surgery, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China. jdeywangmin@ 123456163.com
                Author notes

                Author contributions: Guo Y, Wang S, and Wang M contributed to the conceptualization; Guo Y, Zhao ZY, Shang A, and Li DL contributed to the data curation; Li JN and Wang M contributed to the supervision; Guo Y contributed to the drafting, review, and editing of the manuscript.

                Supported by the Science and Technology Development Project of Jilin Province, No. 3D5197434429; the Youth Program of the National Natural Science Foundation of China, No. 3A4205367429; and the Education Project of Jilin University; No. 419070600046.

                Corresponding author: Min Wang, PhD, Full Professor, Department of General Surgery, The Second Hospital of Jilin University, Changchun, Jilin Province, No. 218 Ziqiang Street, Nanguan District, Changchun 130000, Jilin Province, China. jdeywangmin@ 123456163.com

                Article
                jWJCC.v9.i30.pg9285
                10.12998/wjcc.v9.i30.9285
                8567510
                34786415
                3f2263bd-fb54-48bf-b6cf-7551d6b6c415
                ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

                This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

                History
                : 3 June 2021
                : 30 June 2021
                : 23 August 2021
                Categories
                Case Report

                soft tissue metastasis,skeletal muscle metastasis,ossification,colon cancer, braf mutation,tumor mutation burden,case report

                Comments

                Comment on this article